Skip to main content

Table 4 Results from multivariate analysis - dependent variable: DMP enrollment

From: Selective enrollment in Disease Management Programs for coronary heart disease in Germany – An analysis based on cross-sectional survey and administrative claims data

Variable

Model 1

Model 2

Model 3

Model 4

Model 5

 

B (SE)

OR

95% CI

B (SE)

OR

95% CI

B (SE)

OR

95% CI

B (SE)

OR

95% CI

B (SE)

OR

95% CI

Constant

.79 (.17)

2.21

 

.76 (.17)

2.13

 

.83 (.20)

2.29

 

.64 (.21)

1.89

 

.61 (.21)

1.84

 

Female; ref.: male

-.54 (.07)

0.58

0.51–0.67

-.54 (.07)

0.58

0.51–0.67

-.54 (.07)

0.59

0.51–0.66

-.46 (.07)

0.63

0.55–0.73

-.36 (.10)

0.70

0.57–0.85

Age in years; ref.: <=60

 61–65

.18 (.12)

1.20

0.95–1.51

.18 (.12)

1.19

0.94–1.51

.19 (.12)

1.21

0.96–1.53

.15 (.12)

1.16

0.90–1.50

.14 (.12)

1.15

0.91–1.47

 66–70

.54 (.15)

1.72

1.29–2.30

.54 (.15)

1.72

1.28-2.30

.54 (.15)

1.72

1.23–2.30

.49 (.15)

1.62

1.20–2.19

.49 (.15)

1.63

1.21–2.20

 71–75

.48 (.14)

1.62

1.22–2.15

.49 (.14)

1.63

1.22–2.16

.48 (.15)

1.62

1.22–2.16

.46 (.15)

1.58

1.18–2.11

.45 (.15)

1.57

1.17–2,11

 76–80

.73 (.15)

2.08

1.55–2.79

.73 (.15)

2.08

1.55–2.80

.72 (.15)

2,06

1.53–2.80

.69 (.16)

2,00

1.47–2.70

.68 (.16)

1.97

1.45–2.68

  > = 81

.79 (.16)

2.21

1.61–3.03

.80 (.16)

2.22

1.62–3.04

.78 (.16)

2.18

1.58–3.00

.75 (.17)

2.12

1.53–2.95

.75 (.17)

2.12

1.53–2.95

Net equivalent income; ref.: lowest income < =979€

 980 to 1633€

.11 (.09)

1.12

0.94–1.33

.11 (.09)

1.12

0.94–1.33

.13 (.09)

1.13

0.94–1.34

.14 (.09)

1.14

0.95–1.36

.13 (.09)

1.14

0.95–1.36

  > 1633 to <2449€

-.04 (.10)

0.96

0.79–1.17

-.05 (.10)

0.95

0.79–1.16

-.02 (.10)

0.96

0.80–1.17

-.01 (.10)

0.98

0.80–1.20

-.02 (.10)

0.98

0.80–1.20

 = > 2449€

-.30 (.12)

0.74

0.58–0.94

-.30 (.12)

0.74

0.59–0.94

-.20 (.12)

0.76

0.60–0.96

-.17 (.12)

0.82

0.64–1.04

-.21 (.12)

0.81

0.64–1.03

Employment/retirement status; ref.: old-age pension

 Employed

-.41 (.13)

0.66

0.51–0.85

-.41 (.13)

0.66

0.51–0.86

-.43 (.13)

0.67

0.52–0.87

-.44 (.13)

0.65

0.50–0.85

-.43 (.13)

0.65

0.50–0.85

 Not-employed

-.08 (.14)

0.92

0.70–1.22

-.08 (.14)

0.92

0.70–1.21

-.18 (.15)

0.90

0.67–1.17

-.20 (.14)

0.84

0.63–1.11

-.17 (.15)

0.84

0.63–1.12

Subjective socio-economic status; ref.: lowest subSES

 Medium subSES

-.11 (.08)

0.90

0.77–1.04

-.12 (.08)

0.89

0.76–1.03

-.09 (.08)

0.90

0.77–1.05

-.08 (.08)

0.92

0.79–1.07

-.08 (.08)

0.93

0.80–1.08

 Highest subSES

-.11 (.10)

0.90

0.73–1.10

-.12 (.10)

0.89

0.73–1.09

-.11 (.11)

0.91

0.74–1.12

-.11 (.11)

0.89

0.73–1.10

-.10 (.11)

0.91

0.74–1.12

Urban living area; ref.: rural

-.04 (.07)

0.96

0.84–1.10

-.05 (.07)

0.96

0.84–1.09

-.05 (.07)

0.95

0.83–1.09

-.06 (.07)

0.94

0.82–1.07

-.07 (.07)

0.93

0.81–1.07

Single household; ref.: >1 person in household

.03 (.08)

1.03

0.88–1.21

.04 (.08)

1.04

0.88–1.21

.03 (.08)

1.03

0.88–1.21

.03 (.08)

1.03

0.88–1.21

.03 (.08)

1.03

0.88–1.21

Enrolled in integrated care program

   

.43 (.10)

1.54

1.30–1.87

.45 (.10)

1.54

1.27–1.86

.45 (.10)

1.57

1.30–1.91

.45 (.10)

1.57

1.29–1.90

Level of long term care entitlement; ref.: no entitlement

 Level 1

      

.12 (.21)

1.20

0.80–1.80

.03 (.21)

1.12

0.74–1.69

.31 (.21)

1.03

0.68–1.57

 Level 2

      

-.73 (.30)

0.49

0.27–0.89

-.83 (.31)

0.46

0.25–0.85

-.83 (.31)

0.44

0.24–0.81

Charlson Score; ref.: Charlson Score = 0

 Charlson Score = 1

     

-.10 (.08)

1.18

0.98–1.42

.00 (.80)

1.10

0.91–1.32

.00 (.08)

1.00

0.85–1.17

 Charlson Score = 2

     

.14 (.08)

1.50

1.24–1.81

.19 (.09)

1.33

1.10–1.62

.17 (.09)

1.20

1.02–1.42

 Charlson Score = 3

     

.18 (.10)

1.56

1.28–1.92

.19 (.09)

1.34

1.09–1.64

.19 (.09)

1.20

1.01–1.44

 Charlson Score >3

     

.15 (.10)

1.66

1.38–2.00

.12 (.10)

1.27

1.05–1.55

.12 (.10)

1.12

0.92–1.38

Health related quality of life (VAS 0–100)

     

−0.00 (.00)

1.00

0.99–1.00

−0.00 (.00)

0.99

0.99–1.00

−0.00 (.00)

0.99

0.99–1.00

DM2; ref.: no DM2

       

.97 (.08)

2.65

2.25–3.12

.97 (.09)

2.64

2.24–3.12

Disease Severity: ref.: lowest severity

 Medium severity

         

-.43 (.09)

0.65

0.55–0.77

-.28 (.11)

0.76

0.62–0.93

 Highest severity

         

-.72 (.10)

0.49

0.40–0.59

-.59 (.12)

0.56

0.44–0.70

MI; ref.: no MI

         

.76 (.09)

2.15

1.80–2.56

.58 (.11)

1.80

1.44–2.19

CHF; ref.: no CHF

         

-.07 (.07)

0.94

0.83–1.07

-.01 (.08)

0.99

0.85–1.14

Interaction terms

Medium disease severity*female

          

-.46 (.19)

0.64

0.44–0.92

 High disease severity*female

           

-.46 (.23)

0.63

0.40–1.00

 MI*female

            

.72 (.23)

2.05

1.34–3.13

 CHF*female

            

-.21 (.15)

0.82

0.61–1.10

  1. Bold = p < 0.05
  2. Model 1: Model X 2(8) = 311.19–317.80, p < .001; Hosmer-Lemeshow X 2(8) = 6.42–16.36, p = .04–.60; R2 = .065–.066 (Nagelkerke); Model 2: Model X 2(16) = 336.42–343.13, p < .001; Hosmer-Lemeshow X 2(8) = 3.10–7.62, p = .38–.93; R2 = .070–.071 (Nagelkerke); Model 3: Model X 2(25) = 393.96–402.52, p < .001; Hosmer-Lemeshow X 2(8) = 4.32–13.7, p = .09–.82; R2 = .082–.083 (Nagelkerke); Model 4: Model X 2(30) = 611.52–619.52, p < .001; Hosmer-Lemeshow X 2(8) = 6.39–10.10, p = .26–.60; R2 = .124–.126 (Nagelkerke); Model 5: X 2(34) = 623.84–632.55, p < .001; Hosmer-Lemeshow X 2(8) = 3.62–12.46, p = .13–.89; R2 = .127–.129 (Nagelkerke)
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us